AMI GO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation

Journal of Cell Biology

Volumn 211, Issue 3, 2015, Pages 619-637

  Park, Hyojin ^a   Lee, Sungwoon ^a   Shrestha, Pravesh ^a   Kim, Jihye ^a   Park, Jeong Ae ^a   Ko, Yeongrim ^a   Ban, Young Ho ^a   Park, Dae Young ^e   Ha, Sang Jun ^a   Koh, Gou Young ^e   Hong, Victor Sukbong ^c   Mochizuki, Naoki ^d   Kim, Young Myeong ^b   Lee, Weontae ^a   Kwon, Young Guen ^a  

^a Yonsei University   (South Korea)

^b Kangwon National University   (South Korea)

^c Keimyung University   (South Korea)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION MOLECULE WITH IGG LIKE DOMAIN 2; AMINO ACID; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PLECKSTRIN; PROTEIN KINASE B; SCAFFOLD PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; AMIGO2 PROTEIN, HUMAN; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN-INDUCED RETINOPATHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; CELL MEMBRANE; HUMAN; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

AMINO ACIDS; ANIMALS; APOPTOSIS; CELL MEMBRANE; CELL SURVIVAL; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84980385732     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201503113     Document Type: Article

References (66)

1. Alvarez, Y, O. Astudillo, L. Jensen, A.L. Reynolds, N. Waghorne, D.P. Brazil, Y. Cao, J.J. O'Connor, and B.N. Kennedy. 2009. Selective inhibition of retinal angiogenesis by targeting P13 kinase. PLoS One. 4:e7867. http://dx.doi.org/10.1371/journal.pone.0007867.
2. Bayascas, J.R., S. Wullschleger, K. Sakamoto, J.M. Garcia-Martinez, C. Clacher, D. Komander, D.M.F. van Aalten, K.M. Boini, F. Lang, C. Lipina, et al. 2008. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol. Cell. Biol. 28:3258-3272. http://dx.doi.org/10.1128/MCB.02032-07.
3. Behlke, M.A. 2006. Progress towards in vivo use of siRNAs. Mol. Ther. 13:644-670. http://dx.doi.org/10.1016/j.ymthe.2006.01.001.
4. Bischoff, J. 1995. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol. 5:69-74. http://dx.doi.org/10.1016/S0962-8924(00)88949-7.
5. Bonifazi, P., C. D'Angelo, S. Zagarella, T. Zelante, S. Bozza, A. De Luca, G. Giovannini, S. Moretti, R.G. Iannitti, F. Fallarino, et al. 2010. Intranasally delivered siRNA targeting P13K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 3:193-205. http://dx.doi.org/10.1038/mi.2009.130.
6. Casamayor, A., N.A. Morrice, and D.R. Alessi. 1999. Phosphorylation of Ser- 241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem. J. 342:287-292. http://dx.doi.org/10.1042/bj3420287.
7. Chang, L., P.H. Graham, J. Hao, J. Ni, J. Bucci, P.J. Cozzi, J.H. Kearsley, and Y Li. 2013. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the P13K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis. 4:e875. http://dx.doi.org/10.1038/cddis.2013.407.
8. Chang, Z., Q. Zhang, Q. Feng, J. Xu, T Teng, Q. Luan, C. Shan, Y. Hu, B.A. Hemmings, X. Gao, and Z. Yang. 2010. Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. Dev. Biol. 347:384-391. http://dx.doi.org/10.1016Zj.ydbio.2010.08.033.
9. Chen, X., Y. Zhang, Y. Wang, D. Li, L. Zhang, K. Wang, X. Luo, Z. Yang, Y Wu, and J. Liu. 2013. PDK1 regulates platelet activation and arterial thrombosis. Blood. 121:3718-3726. http://dx.doi.org/10.1182/blood-2012-10-461897.
10. Chen, Y, S. Aulia, L. Li, and B.L. Tang. 2006. AMIGO and friends: An emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res. Brain Res. Rev. 51:265-274. http://dx.doi.org/10.1016/j.brainresrev.2005.11.005.
11. Choi, Y.S., H.J. Choi, J.K. Min, B.J. Pyun, Y.S. Maeng, H. Park, J. Kim, YM. Kim, and Y.G. Kwon. 2009. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood. 114:3117-3126. http://dx.doi.org/10.1182/blood-2009-02-203372.
12. Connor, K.M., N.M. Krah, R.J. Dennison, C.M. Aderman, J. Chen, K.I. Guerin, P. Sapieha, A. Stahl, K.L. Willett, and L.E.H. Smith. 2009. Quantification of oxygen-induced retinopathy in the mouse: A model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4:1565-1573. http://dx.doi.org/10.1038/nprot.2009.187.
13. Datta, S.R., A. Brunet, and M.E. Greenberg. 1999. Cellular survival: A play in three Akts. Genes Dev. 13:2905-2927. http://dx.doi.org/10.1101/gad.13.22.2905.
14. Dimmeler, S., and A.M. Zeiher. 2000a. Akt takes center stage in angiogenesis signaling. Circ. Res. 86:4-5. http://dx.doi.org/10.1161/01.RES.86.1.4.
15. Dimmeler, S., and A.M. Zeiher. 2000b. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87:434-439. http://dx.doi.org/10.1161/01.RES.87.6.434.
16. Feng, Q., R. Di, F. Tao, Z. Chang, S. Lu, W. Fan, C. Shan, X. Li, and Z. Yang. 2010. PDK1 regulates vascular remodeling and promotes epithelialmesenchymal transition in cardiac development. Mol. Cell. Biol. 30:3711-3721. http://dx.doi.org/10.1128/MCB.00420-10.
17. Fujio, Y., and K. Walsh. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274:16349-16354. http://dx.doi.org/10.1074/jbc.274.23.16349.
18. Gao, X., and T.K. Harris. 2006. Role of the PH domain in regulating in vitro autophosphorylation events required for reconstitution of PDK1 catalytic activity. Bioorg. Chem. 34:200-223. http://dx.doi.org/10.1016Zj.bioorg.2006.05.002.
19. Garuti, L., M. Roberti, and G. Bottegoni. 2010. Non-ATP competitive protein kinase inhibitors. Curr. Med. Chem. 17:2804-2821. http://dx.doi.org/10.2174/092986710791859333.
20. Goenaga, D., C. Hampe, N. Carré, K. Cailliau, E. Browaeys-Poly, D. Perdereau, L.J. Holt, R.J. Daly, J. Girard, I. Broutin, et al. 2009. Molecular determinants of Grb14-mediated inhibition of insulin signaling. Mol. Endocrinol. 23:1043-1051. http://dx.doi.org/10.1210/me.2008-0360.
21. Hellesøy, M., and J.B. Lorens. 2015. Cellular context-mediated Akt dynamics regulates MAP kinase signaling thresholds during angiogenesis. Mol. Biol. Cell. 26:2698-2711. http://dx.doi.org/10.1091/mbc.E14-09-1378.
22. Hellesøy, M., A.L. Blois, C.E. Tiron, M. Mannelqvist, L.A. Akslen, and J.B. Lorens. 2014. Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis. Tissue Eng. Part A. 20:2590-2603. http://dx.doi.org/10.1089/ten.tea.2013.0399.
23. Hirai, H., H. Sootome, Y Nakatsuru, K. Miyama, S. Taguchi, K. Tsujioka, Y. Ueno, H. Hatch, P.K. Majumder, B.S. Pan, and H. Kotani. 2010. MK- 2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 9:1956-1967. http://dx.doi.org/10.1158/1535-7163.MCT-09-1012.
24. Hong, C.C., Q.P. Peterson, J.Y. Hong, and R.T. Peterson. 2006. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr. Biol. 16:1366-1372. http://dx.doi.org/10.1016/j.cub.2006.05.046.
25. Hossain, S., M.U. Ahmed, S. Alam, A. Watanabe, A. Harashima, H. Yonekura, and H. Yamamoto. 2011. Expression and roles of AMIGO gene family in vascular endothelial cells. Int. J. Mol. Med. Adv. Sci. 7:5-11. http://dx.doi.org/10.3923/ijmmas.2011.5.11.
26. Huang, B.X., M. Akbar, K. Kevala, and H.Y. Kim. 2011. Phosphatidylserine is a critical modulator for Akt activation. J. Cell Biol. 192:979-992. http://dx.doi.org/10.1083/jcb.201005100.
27. Inaba, S., S. Nagahara, N. Makita, Y. Tarumi, T. Ishimoto, S. Matsuo, K. Kadomatsu, and Y. Takei. 2012. Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals. Mol. Ther. 20:356-366. http://dx.doi.org/10.1038/mt.2011.221.
28. Jiang, B.H., and L.Z. Liu. 2008. P13K/PTEN signaling in tumorigenesis and angiogenesis. Biochim. Biophys. Acta. 1784:150-158. http://dx.doi.org/10.1016/j.bbapap.2007.09.008.
29. King, C.C., and A.C. Newton. 2004. The adaptor protein Grb14 regulates the localization of 3-phosphoinositide-dependent kinase-1. J. Biol. Chem. 279:37518-37527. http://dx.doi.org/10.1074/jbc.M405340200.
30. King, W.G., M.D. Mattaliano, T.O. Chan, P.N. Tsichlis, and J.S. Brugge. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17:4406-4418. http://dx.doi.org/10.1128/MCB.17.8.4406.
31. Kitamura, T., N. Asai, A. Enomoto, K. Maeda, T. Kato, M. Ishida, P. Jiang, T. Watanabe, J. Usukura, T. Kondo, et al. 2008. Regulation of VEGF- mediated angiogenesis by the Akt/PKB substrate Girdin. Nat. Cell Biol. 10:329-337. http://dx.doi.org/10.1038/ncb1695.
32. Kuja-Panula, J., M. Kiiltomäki, T. Yamashiro, A. Rouhiainen, and H. Rauvala. 2003. AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats. J. Cell Biol. 160:963-973. http://dx.doi.org/10.1083/jcb.200209074.
33. Lamalice, L., F. Le Boeuf, and J. Huot. 2007. Endothelial cell migration during angiogenesis. Circ. Res. 100:782-794. http://dx.doi.org/10.1161/01.RES.0000259593.07661.1e.
34. Lim, M.A., C.K. Kikani, M.J. Wick, and L.Q. Dong. 2003. Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. Proc. Natl. Acad. Sci. USA. 100:14006-14011. http://dx.doi.org/10.1073/pnas.2335486100.
35. Liu, W., S.A. Ahmad, N. Reinmuth, R.M. Shaheen, YD, Jung, F. Fan, and L.M. Ellis. 2000. Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis. 5:323-328. http://dx.doi.org/10.1023/A:1009679307513.
36. Lobov, I.B., S. Rao, T.J. Carroll, J.E. Vallance, M. Ito, J.K. Ondr, S. Kurup, D.A. Glass, M.S. Patel, W. Shu, et al. 2005. WNT7b mediates macrophage- induced programmed cell death in patterning of the vasculature. Nature. 437:417-421. http://dx.doi.org/10.1038/nature03928.
37. Maeng, Y.S., H.J. Choi, J.Y. Kwon, Y.W. Park, K.S. Choi, J.K. Min, Y.H. Kim, P.G. Suh, K.S. Kang, M.H. Won, et al. 2009. Endothelial progenitor cell homing: Prominent role of the IGF2-IGF2R-PLCp2 axis. Blood. 113:233-243. http://dx.doi.org/10.1182/blood-2008-06-162891.
38. Mammoto, A., K.M. Connor, T. Mammoto, C.W. Yung, D. Huh, C.M. Aderman, G. Mostoslavsky, L.E.H. Smith, and D.E. Ingber. 2009. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 457:1103-1108. http://dx.doi.org/10.1038/nature07765.
39. Marin, V, G. Kaplanski, S. Gres, C. Farnarier, and P. Bongrand. 2001. Endothelial cell culture: Protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods. 254:183-190. http://dx.doi.org/10.1016/S0022-1759(01)00408-2.
40. Maroulakou, I.G., W. Oemler, S.P. Naber, and P.N. Tsichlis. 2007. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 67:167-177. http://dx.doi.org/10.1158/0008-5472.CAN-06-3782.
41. Martelli, A.M., P.L. Tazzari, G. Tabellini, R. Bortul, A.M. Billi, L. Manzoli, A. Ruggeri, R. Conte, and L. Cocco. 2003. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia. 17:1794-1805. http://dx.doi.org/10.1038/sj.leu.2403044.
42. Meuillet, E.J., S. Zuohe, R. Lemos, N. Ihle, J. Kingston, R. Watkins, S.A. Moses, S. Zhang, L. Du-Cuny, R. Herbst, et al. 2010. Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Mol. Cancer Ther. 9:706-717. http://dx.doi.org/10.1158/1535-7163.MCT-09-0985.
43. Mora, A., D. Komander, D.M.F. van Aalten, and D.R. Alessi. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15:161-170. http://dx.doi.org/10.1016Zj.semcdb.2003.12.022.
44. Nakamura, A., M. Naito, T. Tsuruo, and N. Fujita. 2008. Freud-1/Aki1, a novel PDK1-interacting protein, functions as a scaffold to activate the PDK1/ Akt pathway in epidermal growth factor signaling. Mol. Cell. Biol. 28:5996-6009. http://dx.doi.org/10.1128/MCB.00114-08.
45. Nakamura, T., T. Kuwai, Y Kitadai, T. Sasaki, D. Fan, K.R. Coombes, S.J. Kim, and I.J. Fidler. 2007. Zonal heterogeneity for gene expression in human pancreatic carcinoma. Cancer Res. 67:7597-7604. http://dx.doi.org/10.1158/0008-5472.CAN-07-0874.
46. Ono, T., N. Sekino-Suzuki, Y Kikkawa, H. Yonekawa, and S. Kawashima. 2003. Alivin 1, a novel neuronal activity-dependent gene, inhibits apop- tosis and promotes survival of cerebellar granule neurons. J. Neurosci. 23:5887-5896.
47. Pearce, L.R., D. Komander, and D.R. Alessi. 2010. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11:9-22. http://dx.doi.org/10.1038/nrm2822.
48. Pearn, L., J. Fisher, A.K. Burnett, and R.L. Darley. 2007. The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood. 109:4461-4469. http://dx.doi.org/10.1182/blood-2006-09-047217.
49. Portt, L., G. Norman, C. Clapp, M. Greenwood, and M.T. Greenwood. 2011. Anti-apoptosis and cell survival: A review. Biochim. Biophys. Acta. 1813:238-259. http://dx.doi.org/10.1016/j.bbamcr.2010.10.010.
50. Primo, L., L. di Blasio, C. Roca, S. Droetto, R. Piva, B. Schaffhausen, and F. Bussolino. 2007. Essential role of PDK1 in regulating endothelial cell migration. J. Cell Biol. 176:1035-1047. http://dx.doi.org/10.1083/jcb.200607053.
51. Pullen, N., P. B. Dennis, M. Andjelkovic, A. Dufner, S. C. Kozma, B. A. Hemmings, and G. Thomas. 1998. Phosphorylation and activation of p70s6k by PDK1. Science. 279:707-710. http://dx.doi.org/10.1126/science.279.5351.707.
52. Rabenau, K.E., J.M. O'Toole, R. Bassi, H. Kotanides, L. Witte, D.L. Ludwig, and D.S. Pereira. 2004. DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: Effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene. 23:5056-5067. http://dx.doi.org/10.1038/sj.onc.1207681.
53. Raff, M.C. 1992. Social controls on cell survival and cell death. Nature. 356:397-400. http://dx.doi.org/10.1038/356397a0.
54. Raimondi, C., and M. Falasca. 2011. Targeting PDK1 in cancer. Curr. Med. Chem. 18:2763-2769. http://dx.doi.org/10.2174/092986711796011238.
55. Ren, B., Y Deng, A. Mukhopadhyay, A.A. Lanahan, Z.W. Zhuang, K.L. Moodie, M.J. Mulligan-Kehoe, T.V. Byzova, R.T. Peterson, and M. Simons. 2010. ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J. Clin. Invest. 120:1217-1228. http://dx.doi.org/10.1172/JC139837.
56. Ridley, A.J., M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. Borisy, J.T. Parsons, and A.R. Horwitz. 2003. Cell migration: Integrating signals from front to back. Science. 302:1704-1709. http://dx.doi.org/10.1126/science.1092053.
57. Sheppard, K., K.M. Kinross, B. Solomon, R.B. Pearson, and W.A. Phillips. 2012. Targeting P13 kinase/AKT/mTOR signaling in cancer. Crit. Rev. Oncog. 17:69-95. http://dx.doi.org/10.1615/CritRevOncog.v17.i1.60.
58. Stromblad, S., and D.A. Cheresh. 1996. Cell adhesion and angiogenesis. Trends Cell Biol. 6:462-468. http://dx.doi.org/10.1016/0962-8924(96)84942-7.
59. Sun, J.F., T. Phung, I. Shiojima, T. Felske, J.N. Upalakalin, D. Feng, T. Kornaga, T. Dor, A.M. Dvorak, K. Walsh, and L.E. Benjamin. 2005. Microvascular patterning is controlled by fine-tuning the Akt signal. Proc. Natl. Acad. Sci. USA. 102:128-133. http://dx.doi.org/10.1073/pnas.0403198102.
60. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462. http://dx.doi.org/10.1126/science.7878464.
61. Toker, A., and A.C. Newton. 2000. Cellular signaling: Pivoting around PDK-1. Cell. 103:185-188. http://dx.doi.org/10.1016/S0092-8674(00)00110-0.
62. Vicent, D., J. Ilany, T. Kondo, K. Naruse, S.J. Fisher, YY. Kisanuki, S. Bursell, M. Yanagisawa, G.L. King, and C.R. Kahn. 2003. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111:1373-1380. http://dx.doi.org/10.1172/JC115211.
63. Vivanco, I., and C.L. Sawyers. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2:489-501. http://dx.doi.org/10.1038/nrc839.
64. Wu, Y., Q. Li, and X.Z. Chen. 2007. Detecting protein-protein interactions by far western blotting. Nat. Protoc. 2:3278-3284. http://dx.doi.org/10.1038/nprot.2007.459.
65. Xia, C., Q. Meng, Z. Cao, X. Shi, and B.H. Jiang. 2006. Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J. Cell. Physiol. 209:56-66. http://dx.doi.org/10.1002/jcp.20707.
66. Yamada, T., S. Takeuchi, N. Fujita, A. Nakamura, W. Wang, Q. Li, M. Oda, T. Mitsudomi, Y Yatabe, Y. Sekido, et al. 2013. Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations. Oncogene. 32:4427-4435. http://dx.doi.org/10.1038/onc.2012.446.